Q1 2023 13F Holders as of 3/31/2023
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
679K
-
Shares change
-
-17.8K
-
Total reported value, excl. options
-
$1.85M
-
Value change
-
-$43.4K
-
Number of buys
-
5
-
Number of sells
-
-4
-
Price
-
$2.72
Significant Holders of Lexaria Bioscience Corp. - COM NEW (LEXX) as of Q1 2023
16 filings reported holding LEXX - Lexaria Bioscience Corp. - COM NEW as of Q1 2023.
Lexaria Bioscience Corp. - COM NEW (LEXX) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 679K shares
.
Largest 10 shareholders include Invenomic Capital Management LP (473K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (67.5K shares), GEODE CAPITAL MANAGEMENT, LLC (48.8K shares), VANGUARD GROUP INC (33.3K shares), DIMENSIONAL FUND ADVISORS LP (15.3K shares), RENAISSANCE TECHNOLOGIES LLC (13.6K shares), Centiva Capital, LP (12.1K shares), UBS Group AG (4.64K shares), Tower Research Capital LLC (TRC) (4.02K shares), and 1832 Asset Management L.P. (2.69K shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.